At Angiotech, we are redefining success by striving to create novel medical solutions that elevate the standard of care and improve people's lives.
Angiotech is Redefining Success
- Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. We are listed on both the TSX and NASDAQ stock exchanges (NASDAQ: ANPI, TSX: ANP). Read More...
If you are a Healthcare Professional and would like to learn more about Angiotech's products, please visit AngioEduPRO.com; Angiotech's Educational Resource for Healthcare Professionals.
Press Releases
- March 4 - Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Fourth Quarter Ended December 31, 2009 Read More...
- February 17 - Angiotech Pharmaceuticals and Partner Athersys Announces Completion of Patient Enrollment in Phase I Study of MultiStem® in Acute Mycardial Infarction Read More...
- All Press Releases
Highlights
- Angiotech sets March 4th as date for Fourth Quarter and Year End 2009 Financial Results Read More...
- Angiotech's Annual General Meeting Presentation View Now...
